| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 634794 | Null | 0.0016558732586581 | 0.1584311 |
| NSC 635450 | Null | 0.0016558732586581 | 0.4935438 |
| NSC 639977 | Null | 0.0016558732586581 | 0.46191512 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0016558732586581 | 0.31515075 |
| NSC 740024 | 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine | 0.0016558732586581 | 0.23750972 |
| NSC 87222 | ACTINOMYCIN C3 | 0.0016558732586581 | 0.42945593 |
| NSC 374998 | 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyrimidinyl)ethylidene] hydrazide | 0.0018088833864761 | 0.52952615 |
| NSC 628917 | 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide | 0.0018088833864761 | 0.48933609 |
| NSC 691201 | Null | 0.0018088833864761 | 0.20593104 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.00181889981954878 | 0.48321632 |